CLINICAL TRIALS PROFILE FOR LURASIDONE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for lurasidone hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00044005 ↗ | Safety and Tolerability Study of Drug to Treat Schizophrenia | Completed | Sunovion | Phase 2 | 2002-09-01 | The purpose of this study is to evaluate the long-term safety of SM-13496 in patients with schizophrenia. |
NCT00088621 ↗ | A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia | Completed | Sunovion | Phase 2 | 2004-07-01 | A 1-year outpatient study to test the safety and tolerability of a new medication in the treatment of schizophrenia |
NCT00088634 ↗ | A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia | Completed | Sunovion | Phase 2 | 2004-05-01 | A 6-week in-patient and out-patient study to test the effectiveness and safety of a new medication in the treatment of schizophrenia |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for lurasidone hydrochloride
Condition Name
Clinical Trial Locations for lurasidone hydrochloride
Trials by Country
Clinical Trial Progress for lurasidone hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for lurasidone hydrochloride
Sponsor Name